FDA
-
-
-
-
-
-
-
BioNTech (BNTX) PT Lowered to $94 at Leerink Partners
-
-
-
-
-
-
-
FDA Probe Of Alleged Deaths Tied To Covid Shots Includes Adults
-
-
-
-
-
-
-
BMO Capital: ACIP Cuts a Broad Negative To the Vaccine Space
-
-
-
-
-
-
-
BioNTech SE (BNTX) says FDA placed clinical hold on IND and related Phase I/IIa clinical trial of BNT165e
-
-
-
-
-
-
-
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on BioNTech (BNTX)
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioNTech, Mobileye, BioVie, and ADM and Encourages Investors to Contact the Firm
-
330,173 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

